1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on April 1, 2025

High Growth Tech Stocks To Watch In The US April 2025
ABBV

Simply Wall St.

9 hours ago

High Growth Tech Stocks To Watch In The US April 2025

MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…
ABBV

Zacks Small Cap Research

a day ago

MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…

AbbVie to Host First-Quarter 2025 Earnings Conference Call
ABBV

PR Newswire

a day ago

AbbVie to Host First-Quarter 2025 Earnings Conference Call

ABBV

Argus Research

a day ago

Technical Assessment: Neutral in the Intermediate-Term

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
ABBV

Motley Fool

a day ago

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

AbbVie Inc. (ABBV): Among the Best Dividend Aristocrat Stocks with Over 3% Yield
ABBV

Insider Monkey

2 days ago

AbbVie Inc. (ABBV): Among the Best Dividend Aristocrat Stocks with Over 3% Yield

3 Relatively Safe Stocks to Buy Right Now
ABBV

Motley Fool

3 days ago

3 Relatively Safe Stocks to Buy Right Now

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
ABBV

Zacks

5 days ago

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug
ABBV

Zacks

5 days ago

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...
ABBV

GuruFocus.com

6 days ago

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...

AbbVie (NYSE:ABBV) Showcases Oncology Innovations Amidst 6% Share Price Dip
ABBV

Simply Wall St.

6 days ago

AbbVie (NYSE:ABBV) Showcases Oncology Innovations Amidst 6% Share Price Dip

AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025
ABBV

PR Newswire

6 days ago

AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025

These Dividend Stocks Can Protect You From the Next Market Drop
ABBV

Barrons.com

6 days ago

These Dividend Stocks Can Protect You From the Next Market Drop

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income
ABBV

Motley Fool

6 days ago

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income

S&P 500 Gains and Losses Today: International Paper Stock Pops on Upbeat Growth Outlook
ABBV

Investopedia

7 days ago

S&P 500 Gains and Losses Today: International Paper Stock Pops on Upbeat Growth Outlook

3 Healthcare Stocks in the Doghouse
ABBV

StockStory

7 days ago

3 Healthcare Stocks in the Doghouse

5 Large Drug Stocks to Watch as Industry Recovers
ABBV

Zacks

7 days ago

5 Large Drug Stocks to Watch as Industry Recovers

AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why
ABBV

Zacks

8 days ago

AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why

ABBV

MT Newswires

8 days ago

Genmab Denies Trade Secret Misappropriation Claims by AbbVie

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
ABBV

StockStory

8 days ago

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025
ABBV

PR Newswire

9 days ago

Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025

Is AbbVie Inc. (ABBV) The Best Healthcare Dividend Stock to Invest in?
ABBV

Insider Monkey

9 days ago

Is AbbVie Inc. (ABBV) The Best Healthcare Dividend Stock to Invest in?

Unlocking Intrinsic Value: Analysis of AbbVie Inc
ABBV

GuruFocus.com

11 days ago

Unlocking Intrinsic Value: Analysis of AbbVie Inc

J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease
ABBV

Zacks

11 days ago

J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease

Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends
ABBV

Motley Fool

12 days ago

Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends

ABBV

Argus Research

12 days ago

Daily – Vickers Top Buyers & Sellers for 03/20/2025

3 Dividend Stocks to Buy for Reliable Passive Income
ABBV

Motley Fool

13 days ago

3 Dividend Stocks to Buy for Reliable Passive Income

AbbVie (ABBV) Stock Moves -0.29%: What You Should Know
ABBV

Zacks

14 days ago

AbbVie (ABBV) Stock Moves -0.29%: What You Should Know

ABBV

MT Newswires

14 days ago

Abbvie Insider Sold Shares Worth $3,746,527, According to a Recent SEC Filing

AbbVie upgraded to Buy at Erste Group on Friday
ABBV

TipRanks

14 days ago

AbbVie upgraded to Buy at Erste Group on Friday

AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer
ABBV

Clinical Trials Arena

15 days ago

AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer

The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands
ABBV

Zacks

15 days ago

The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands

1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction
ABBV

Motley Fool

16 days ago

1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction

AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer
ABBV

Simply Wall St.

16 days ago

AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer

ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
ABBV

PR Newswire

17 days ago

ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

Top Analyst Reports for AbbVie, Lockheed Martin & Dell
ABBV

Zacks

18 days ago

Top Analyst Reports for AbbVie, Lockheed Martin & Dell

ABBV

Thomson Reuters StreetEvents

18 days ago

Q4 2024 Regenxbio Inc Earnings Call

3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
ABBV

Motley Fool

18 days ago

3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
ABBV

The Wall Street Journal

18 days ago

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
ABBV

Zacks

19 days ago

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds
ABBV

Insider Monkey

20 days ago

Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds

Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%
ABBV

Yahoo Finance

20 days ago

Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply
ABBV

Zacks

20 days ago

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply

Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.
ABBV

Motley Fool

20 days ago

Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.

ABBV

MT Newswires

20 days ago

Berenberg Adjusts Price Target on AbbVie to $195 From $165, Maintains Hold Rating

Why AbbVie (ABBV) Dipped More Than Broader Market Today
ABBV

Zacks

21 days ago

Why AbbVie (ABBV) Dipped More Than Broader Market Today

AbbVie (NYSE:ABBV) Urges Shareholders To Reject Proposals On Voting Rules And Human Rights Due Diligence
ABBV

Simply Wall St.

21 days ago

AbbVie (NYSE:ABBV) Urges Shareholders To Reject Proposals On Voting Rules And Human Rights Due Diligence

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
ABBV

StockStory

21 days ago

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

AbbVie Inc. (ABBV): A Magnificent Dividend Growth Stock to Invest In
ABBV

Insider Monkey

21 days ago

AbbVie Inc. (ABBV): A Magnificent Dividend Growth Stock to Invest In

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out
ABBV

Investor's Business Daily

22 days ago

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now?
ABBV

Insider Monkey

22 days ago

Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now?

Zacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie
ABBV

Zacks

22 days ago

Zacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie

ABBV

MT Newswires

22 days ago

Redburn Atlantic Adjusts Price Target on AbbVie to $234 From $216

This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?
ABBV

Motley Fool

22 days ago

This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?

AbbVie Inc. (ABBV): Among The Stocks With At Least $10 Million In Insider Sales Recently
ABBV

Insider Monkey

25 days ago

AbbVie Inc. (ABBV): Among The Stocks With At Least $10 Million In Insider Sales Recently

3 Stocks Breaking Out Right Now
ABBV

Zacks

25 days ago

3 Stocks Breaking Out Right Now

Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
ABBV

Zacks

25 days ago

Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?

Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More
ABBV

Zacks

25 days ago

Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More

3 Cheap Stocks to Buy With Your Tax Refund Check
ABBV

Motley Fool

25 days ago

3 Cheap Stocks to Buy With Your Tax Refund Check

2 Dividend Stocks to Buy for a Lifetime of Passive Income
ABBV

Motley Fool

25 days ago

2 Dividend Stocks to Buy for a Lifetime of Passive Income

Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out
ABBV

Barrons.com

a month ago

Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out

AbbVie (NYSE:ABBV) Expands SKYRIZI Availability In Canada For Ulcerative Colitis Treatment
ABBV

Simply Wall St.

a month ago

AbbVie (NYSE:ABBV) Expands SKYRIZI Availability In Canada For Ulcerative Colitis Treatment

Here's How to Play AbbVie Stock as it Enters the Obesity Space
ABBV

Zacks

a month ago

Here's How to Play AbbVie Stock as it Enters the Obesity Space

ABBV

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 03/05/2025

ABBV

MT Newswires

a month ago

Wells Fargo Adjusts Price Target on AbbVie to $240 From $210, Keeps Overweight Rating

Ariel Global Fund Added AbbVie (ABBV) on Dip
ABBV

Insider Monkey

a month ago

Ariel Global Fund Added AbbVie (ABBV) on Dip

AbbVie to Present at the Leerink Partners Global Healthcare Conference
ABBV

PR Newswire

a month ago

AbbVie to Present at the Leerink Partners Global Healthcare Conference

SKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease
ABBV

CNW Group

a month ago

SKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease

ABBV

MT Newswires

a month ago

TD Cowen Adjusts Price Target on AbbVie to $250 From $225, Maintains Buy Rating

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

a month ago

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
ABBV

StockStory

a month ago

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

AbbVie Inc. (ABBV): Among the Best S&P 500 Dividend Stocks to Buy Now
ABBV

Insider Monkey

a month ago

AbbVie Inc. (ABBV): Among the Best S&P 500 Dividend Stocks to Buy Now

AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts
ABBV

Zacks

a month ago

AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts

AbbVie enters obesity space with $2.3bn Gubra deal
ABBV

Pharmaceutical Technology

a month ago

AbbVie enters obesity space with $2.3bn Gubra deal

ABBV

MT Newswires

a month ago

AbbVie Enters License Deal With Gubra to Develop Obesity Treatment

AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
ABBV

PR Newswire

a month ago

AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now?
ABBV

Insider Monkey

a month ago

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now?

Insiders At AbbVie Sold US$23m In Stock, Alluding To Potential Weakness
ABBV

Simply Wall St.

a month ago

Insiders At AbbVie Sold US$23m In Stock, Alluding To Potential Weakness

AbbVie Inc. (ABBV): Among the Best Psychedelic Stocks to Buy in 2025
ABBV

Insider Monkey

a month ago

AbbVie Inc. (ABBV): Among the Best Psychedelic Stocks to Buy in 2025

AbbVie's Next Big Moneymaker? This Drug Just Took a Huge Step Toward Approval
ABBV

GuruFocus.com

a month ago

AbbVie's Next Big Moneymaker? This Drug Just Took a Huge Step Toward Approval

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down
ABBV

Zacks

a month ago

IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down

CHMP recommends AbbVie’s Rinvoq be approved for adult GCA
ABBV

Pharmaceutical Technology

a month ago

CHMP recommends AbbVie’s Rinvoq be approved for adult GCA

Drug Stocks Are the New Safe Bet in a Shaky Market
ABBV

The Wall Street Journal

a month ago

Drug Stocks Are the New Safe Bet in a Shaky Market

ABBV

MT Newswires

a month ago

AbbVie Receives Positive Opinion on Giant Cell Arteritis Therapy From European Medicines Agency

3 Reasons ABBV is Risky and 1 Stock to Buy Instead
ABBV

StockStory

a month ago

3 Reasons ABBV is Risky and 1 Stock to Buy Instead

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis
ABBV

PR Newswire

a month ago

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript
ABBV

Motley Fool

a month ago

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript

ABBV

MT Newswires

a month ago

HSBC Adjusts AbbVie Price Target to $230 From $220, Maintains Buy Rating

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
ABBV

Motley Fool

a month ago

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

High Growth Tech Stocks To Watch In February 2025
ABBV

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In February 2025

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
ABBV

Zacks

a month ago

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It

AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference
ABBV

PR Newswire

a month ago

AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

a month ago

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value

Is AbbVie Inc. (ABBV) the Best DRIP Stock to Own Now?
ABBV

Insider Monkey

a month ago

Is AbbVie Inc. (ABBV) the Best DRIP Stock to Own Now?

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market
ABBV

Pharmaceutical Technology

a month ago

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

AbbVie Inc. (ABBV): Among S&P 500 Dividend Aristocrats List
ABBV

Insider Monkey

a month ago

AbbVie Inc. (ABBV): Among S&P 500 Dividend Aristocrats List

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic
ABBV

Zacks

a month ago

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

2 High-Yield Dividend ETFs to Buy to Generate Passive Income
ABBV

Motley Fool

a month ago

2 High-Yield Dividend ETFs to Buy to Generate Passive Income

4 Seniors & Aging Demographics Stocks to Watch Right Now
ABBV

Zacks

a month ago

4 Seniors & Aging Demographics Stocks to Watch Right Now

Some May Be Optimistic About AbbVie's (NYSE:ABBV) Earnings
ABBV

Simply Wall St.

a month ago

Some May Be Optimistic About AbbVie's (NYSE:ABBV) Earnings

Share on Social Networks: